ALEXION PHARMACEUTICALS, INC. Insider Trading for February 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALEXION PHARMACEUTICALS, INC. for February 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10 2017 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 126.84 | 246 | 31,203 | 394,648 | 394.9 K to 394.6 K (-0.06 %) |
| Feb 10 2017 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Sell | S | 126.84 | 167 | 21,182 | 34,840 | 35 K to 34.8 K (-0.48 %) |
| Feb 10 2017 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 126.84 | 217 | 27,524 | 39,743 | 40 K to 39.7 K (-0.54 %) |
| Feb 10 2017 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 126.84 | 167 | 21,182 | 46,476 | 46.6 K to 46.5 K (-0.36 %) |
| Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Sell | S | 128.09 | 166 | 21,263 | 35,007 | 35.2 K to 35 K (-0.47 %) |
| Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Sell | S | 126.65 | 24 | 3,040 | 35,173 | 35.2 K to 35.2 K (-0.07 %) |
| Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Sell | S | 125.69 | 3,380 | 424,832 | 35,197 | 38.6 K to 35.2 K (-8.76 %) |
| Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | O'Neill Julie | EVP. Global Operati ... | Sell | S | 125.69 | 2,795 | 351,304 | 32,589 | 35.4 K to 32.6 K (-7.90 %) |
| Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 128.09 | 135 | 17,292 | 46,643 | 46.8 K to 46.6 K (-0.29 %) |
| Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 126.38 | 23 | 2,907 | 46,778 | 46.8 K to 46.8 K (-0.05 %) |
| Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 125.69 | 3,380 | 424,832 | 46,801 | 50.2 K to 46.8 K (-6.74 %) |
| Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 128.09 | 1,010 | 129,371 | 394,894 | 395.9 K to 394.9 K (-0.26 %) |
| Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 126.09 | 75 | 9,457 | 395,904 | 396 K to 395.9 K (-0.02 %) |
| Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 125.69 | 7,640 | 960,272 | 395,979 | 403.6 K to 396 K (-1.89 %) |
| Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Sell | S | 126.95 | 9 | 1,143 | 15,474 | 15.5 K to 15.5 K (-0.06 %) |
| Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Sell | S | 125.69 | 1,036 | 130,215 | 15,483 | 16.5 K to 15.5 K (-6.27 %) |
| Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | Thiel Carsten | EVP, Chief Commerci ... | Sell | S | 125.69 | 165 | 20,739 | 30,268 | 30.4 K to 30.3 K (-0.54 %) |
| Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 126.88 | 18 | 2,284 | 39,960 | 40 K to 40 K (-0.05 %) |
| Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 125.69 | 2,710 | 340,620 | 39,978 | 42.7 K to 40 K (-6.35 %) |
| Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | Wagner Heidi L | SVP, Global Governm ... | Sell | S | 128.09 | 222 | 28,436 | 30,004 | 30.2 K to 30 K (-0.73 %) |
| Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | Wagner Heidi L | SVP, Global Governm ... | Sell | S | 126.04 | 15 | 1,891 | 30,226 | 30.2 K to 30.2 K (-0.05 %) |
| Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | Wagner Heidi L | SVP, Global Governm ... | Sell | S | 125.69 | 1,695 | 213,045 | 30,241 | 31.9 K to 30.2 K (-5.31 %) |